The latest launch from Thrive IV offers an effective intervention for the treatment of severe and medication-resistant depression in patients of all ages. The clinic’s ketamine infusions provide a safe and fast-acting solution.
More details can be found at http://www.thriveiv.net
The announcement outlines what clients can expect from their visits to the center with the team offering a detailed consultation and bespoke treatment plan for each patient. Typically, a series of six infusions prove effective for depressive disorders, delivered over a two to three-week period.
According to an article published by the Neuropsychiatric Disease and Treatment journal, ketamine appears to have anti-depressive and anti-suicidal effects on those suffering from bipolar disorder (BD). Treatment failure rates and suicide risks are higher for BD patients than for those with major depressive disorder. BD currently affects around 1% of the population as per the Journal of Clinical Psychiatry.
Thrive IV can help clients for whom standard anti-depressant medications have proved ineffective. However, the ketamine infusion can both support and be taken in conjunction with existing pharmaceutical drugs as prescribed by a physician.
The clinic ensures all clients are made as comfortable as possible during the procedure with a soft, reclining chair, calm lighting, and gently uplifting music to soundtrack the sessions. Appointments last between 40 minutes and one hour and include a low-dose infusion and around 20 minutes of recovery time.
Patients’ vital signs are monitored throughout the procedure to ensure their safety and well-being at all times.
About Thrive IV
Led by Dr. Michael Pellegrino – a 1991 graduate of UNECOM Medical School who has been caring for patients in the Southern Massachusetts area since 1996. Thrive IV is built on a commitment to exploring and utilizing the potential of a wide variety of therapies, combining traditional treatments with complementary approaches to help patients find relief from conditions such as depression, anxiety, PTSD, and fibromyalgia.
A spokesperson says, “Treatment-resistant depression (TRD), Bipolar and PPD typically refers to inadequate response to at least one antidepressant trial of adequate doses and duration. Ketamine therapy has been shown to help as many as 70-80% or more in some studies. We specialize in adding Ketamine infusions to help increase the feeling of well-being and reduce terrible pain, depression, or anxiety.”
For more information, go to http://www.thriveiv.net Located near New Bedford and Providence, RI with easy access off main highways.
49 State Rd
Nauset Building #102
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Edition Biz journalist was involved in the writing and production of this article.